For IIR members only

Biologics cold chain : global figures

Between 2006 and 2012, biologics sales doubled to reach USD 124 billion and grew from 14% of over-the-counter pharmaceutical sales to 21%.
<

__truncato_root__>Between 2006 and 2012, biologics sales doubled to reach USD 124 billion and grew from 14% of over-the-counter pharmaceutical sales to 21%.

Such growth will continue to raise demand for cold-chain infrastructure over the near to medium term. This could potentially caus...

IIR members only

You must be an IIR member to read the rest of this article.

Members benefit from exclusive advantages and services.

To find out more, please click on the link below:


Already a member?